Cargando…
Request for regulatory guidance for cancer cachexia intervention trials
Autores principales: | Fearon, KCH, Argiles, JM, Baracos, VE, Bernabei, R, Coats, AJS, Crawford, J, Deutz, NE, Doehner, W, Evans, WJ, Ferrucci, L, Garcia, JM, Gralla, RJ, Jatoi, A, Kalantar-Zadeh, K, Lainscak, M, Morley, JE, Muscaritoli, M, Polkey, MI, Rosano, G, Rossi-Fanelli, F, Schols, AM, Strasser, F, Vellas, B, von Haehling, S, Anker, SD |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4670733/ https://www.ncbi.nlm.nih.gov/pubmed/26675232 http://dx.doi.org/10.1002/jcsm.12083 |
Ejemplares similares
-
Sarcopenia: A Time for Action. An SCWD Position Paper
por: Bauer, Juergen, et al.
Publicado: (2019) -
Muscle wasting disease: a proposal for a new disease classification
por: Anker, Stefan D., et al.
Publicado: (2014) -
Orphan disease status of cancer cachexia in the USA and in the European Union: a systematic review
por: Anker, Markus S., et al.
Publicado: (2019) -
The obesity paradox in chronic disease: facts and numbers
por: Lainscak, Mitja, et al.
Publicado: (2012) -
Single baseline serum creatinine measurements predict mortality in critically ill patients hospitalized for acute heart failure
por: Schefold, Joerg C., et al.
Publicado: (2015)